FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to an uncoated pharmaceutical composition and a method for its preparation. The uncoated pharmaceutical composition contains racecadotrile, co-crystallized sugar, and pharmacologically acceptable inert excipients selected from diluents, binders, sweetener, baking powder, solvents, lubricants, slip-promoting substances, and flavorings, in which the ratio of racecadotrile to co-crystallized sugar is 1:98.75. The method for preparing an uncoated pharmaceutical composition includes the steps of: (a) sieving racecadotrile, part of the co-crystallized sugar, and pharmacologically acceptable inert excipients to produce a mixture; (b) adding a solvent to polyvinylpyrrolidone to produce a solution or suspension; (c) granulating the mixture obtained in step (a) with the solution or suspension obtained in step (b), to obtain granules; (d) drying of granules obtained in step (c); (e) mixing the other part of the co-crystallized sugar with silicon dioxide to produce an intermediate mixture; (f) mixing the dried granules obtained in step (d) and the intermediate mixture obtained in step (e) to produce the final mixture; (g) filling the final mixture obtained in step (f) in a sachet of suitable size.
EFFECT: above-described pharmaceutical composition obtained by the above-described method does not include an optional and complex coating process, and at the same time has an appropriate taste.
9 cl, 1 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ZOLPIDEM COMPOSITION AND A METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2690159C1 |
PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2493831C2 |
SOLID MEDICINAL FORM, CONTAINING PROTON PUMP INHIBITOR, AND SUSPENSION OBTAINED FROM IT | 2005 |
|
RU2397756C2 |
FIZZY COMPOSITIONS BASED ON ORNITHINE ASPARTATE | 2016 |
|
RU2734417C2 |
PERORAL DABIGATRAN ETEXILATE PHARMACEUTICAL COMPOSITIONS | 2013 |
|
RU2633482C2 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
PHARMACEUTICAL COMPOSITION COMPRISING IRON OXY-HYDROXIDE, METHOD OF PRODUCTION THEREOF AND USE | 2013 |
|
RU2648760C2 |
PHARMACEUTICAL COMPOSITION CONTAINING PARP INHIBITORS | 2019 |
|
RU2785677C1 |
PHARMACEUTICAL PREPARATION | 2020 |
|
RU2822063C2 |
SEDATIVE AND SPASMOLITHIC MEANS AND METHOD FOR ITS PRODUCTION | 2015 |
|
RU2633064C2 |
Authors
Dates
2021-06-21—Published
2018-02-20—Filed